A detailed history of Umb Bank, N.A. transactions in Grifols Sa stock. As of the latest transaction made, Umb Bank, N.A. holds 358 shares of GRFS stock, worth $2,688. This represents 0.0% of its overall portfolio holdings.

Number of Shares
358
Previous 358 -0.0%
Holding current value
$2,688
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 26, 2024

SELL
$5.47 - $11.38 $2,286 - $4,756
-418 Reduced 53.87%
358 $2,000
Q4 2023

Jan 23, 2024

BUY
$7.71 - $11.56 $385 - $578
50 Added 6.89%
776 $8,000
Q3 2023

Oct 18, 2023

BUY
$8.91 - $10.91 $5,497 - $6,731
617 Added 566.06%
726 $6,000
Q1 2023

Apr 11, 2023

SELL
$6.65 - $10.69 $1,090 - $1,753
-164 Reduced 60.07%
109 $0
Q4 2022

Jan 10, 2023

BUY
$5.96 - $8.53 $649 - $929
109 Added 66.46%
273 $2,000
Q4 2021

Feb 09, 2022

BUY
$10.21 - $15.27 $1,674 - $2,504
164 New
164 $2,000

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.1B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Umb Bank, N.A. Portfolio

Follow Umb Bank, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Umb Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Umb Bank, N.A. with notifications on news.